These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Striatal 123I-Ioflupane SPECT abnormality in sporadic Creutzfeldt-Jakob disease. Hinnell C; Buxton-Thomas M; Sibtain N; Samuel M J Neurol; 2011 May; 258(5):948-50. PubMed ID: 21174113 [No Abstract] [Full Text] [Related]
63. Creutzfeldt-Jakob disease with reference to the safety of pituitary growth hormone. Bannister BA; McCormick A J Infect; 1987 Jan; 14(1):7-12. PubMed ID: 3546511 [No Abstract] [Full Text] [Related]
64. Early electroretinogram alterations in Creutzfeldt-Jakob disease after growth hormone treatment. Renault F; Richard P Lancet; 1991 Jul; 338(8760):191. PubMed ID: 1677094 [No Abstract] [Full Text] [Related]
65. Human growth hormone and Creutzfeldt-Jakob disease. Raiti S Ann Intern Med; 1985 Aug; 103(2):288-9. PubMed ID: 3893258 [No Abstract] [Full Text] [Related]
66. Preparation of growth hormone free from contamination with unconventional slow viruses. Taylor DM; Dickinson AG; Fraser H; Robertson PA; Salacinski PR; Lowry PJ Lancet; 1985 Aug; 2(8449):260-2. PubMed ID: 2862429 [No Abstract] [Full Text] [Related]
67. Computed tomography during Creutzfeldt-Jakob disease. Westphal KP; Schachenmayr W Neuroradiology; 1985; 27(4):362-4. PubMed ID: 3900802 [TBL] [Abstract][Full Text] [Related]
68. Suspension of the Australian human pituitary hormone programme. Lazarus L Med J Aust; 1985 Jul; 143(2):57-9. PubMed ID: 3894895 [No Abstract] [Full Text] [Related]
69. Virus scare halts hormone research. Norman C Science; 1985 Jun; 228(4704):1176-7. PubMed ID: 3890183 [No Abstract] [Full Text] [Related]
71. FDA ban on pituitary product. Beardsley T Nature; 1985 May 30-Jun 5; 315(6018):358-9. PubMed ID: 3889659 [No Abstract] [Full Text] [Related]
72. A Creutzfeldt-Jakob-like syndrome due to polypharmacy. Waldman AJ South Med J; 1990 Dec; 83(12):1493. PubMed ID: 2251544 [No Abstract] [Full Text] [Related]
73. Anakinra in Creutzfeldt-Jakob disease. Bomboi G; Bernardo ML; Mei D; Falcone NP; Vannicola M Acta Neurol Belg; 2023 Apr; 123(2):705-707. PubMed ID: 35639257 [No Abstract] [Full Text] [Related]
74. [Topodiagnosis of Creutzfeldt-Jakob disease using HMPAO-SPECT]. Heye N; Farahati J; Heinz A; Büttner T; Przuntek H; Reiners C Nuklearmedizin; 1993 Feb; 32(1):57-9. PubMed ID: 8464762 [TBL] [Abstract][Full Text] [Related]
76. [Nuclear medicine in neurology]. Léveillé J; Soucy JP Union Med Can; 1990; 119(4):168-72. PubMed ID: 2201114 [No Abstract] [Full Text] [Related]
77. Single photon emission tomography in growth-hormone related Creutzfeldt-Jakob disease. Markus HS; Harrison MJ; Costa DC Lancet; 1991 Sep; 338(8767):630-1. PubMed ID: 1679165 [No Abstract] [Full Text] [Related]
78. Tc-99m HMPAO brain SPECT findings in Creutzfeldt-Jakob disease. Kao CH; Wang SJ; Liao SQ; Yeh SH Clin Nucl Med; 1993 Mar; 18(3):234-6. PubMed ID: 8462216 [TBL] [Abstract][Full Text] [Related]